Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Crinetics Pharmaceuticals Inc shares valued at $86,021 were sold by Pizzuti Dana on Mar 19 ’25. At $34.20 per share, Pizzuti Dana sold 2,515 shares. The insider’s holdings dropped to 72,233 shares worth approximately $2.52 million following the completion of this transaction.
Also, Knight Jeff E. sold 7,162 shares, netting a total of over 244,964 in proceeds. Following the sale of shares at $34.20 each, the insider now holds 87,491 shares.
Before that, Betz Stephen F. had sold 5,770 shares from its account. In a trade valued at $197,353, the Chief Scientific Officer traded Crinetics Pharmaceuticals Inc shares for $34.20 each. Upon closing the transaction, the insider’s holdings decreased to 5,770 shares, worth approximately $3.79 million.
As published in their initiating research note from Stifel on March 25, 2025, Crinetics Pharmaceuticals Inc [CRNX] has been a Buy and the price target has been revised to $60. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in mid February. As of February 04, 2025, Wolfe Research has initiated its “Peer perform” rating for CRNX. Earlier on January 22, 2025, Jefferies upgraded its rating. Their new recommendation was “a Buy” for CRNX stock which previously was a “a Hold”.
Analyzing CRNX Stock Performance
During the last five days, there has been a surge of approximately 1.66%. Over the course of the year, Crinetics Pharmaceuticals Inc shares have dropped approximately -31.74%. Shares of the company reached a 52-week high of $53.55 on 01/03/25 and a 52-week low of $31.84 on 02/25/25. A 50-day SMA is recorded $36.08, while a 200-day SMA reached $48.42.
Support And Resistance Levels for Crinetics Pharmaceuticals Inc (CRNX)
According to the 24-hour chart, there is a support level at 34.33, which, if violated, would cause prices to drop to 33.75. In the upper region, resistance lies at 35.28. The next price resistance is at 35.66. RSI (Relative Strength Index) is 47.78 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.10, which suggests the price will decrease in the coming days. Percent R is at 41.06%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
